AKT1 and cancer: The KEGG result showed that these targets were mainly enriched in tumor-associated pathways, such as the pathway in cancer; the PI3K-AKT signaling pathway; immune pathways, such as the chemokine signaling pathway and the apoptosis signaling pathway (Figure 2(b)).